The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Prothrombin Complex Concentrate (PCC) Drug Market Research Report 2025
Synopsis
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available. It may also be used in those with not enough of these factors due to other reasons such as warfarin therapy. It is given by slow injection into a vein.
The global Prothrombin Complex Concentrate (PCC) Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In Europe and United States market, key players of prothrombin complex concentrate (PCC) drug include CSL Behring, Grifols, Octapharma, Prothya Biosolutions, Takeda, etc. The top one player hold a share about 58%. United States is the largest market, has a share about 47%, followed by Germany, and France, with share 13% and 12%, separately.
This report aims to provide a comprehensive presentation of the global market for Prothrombin Complex Concentrate (PCC) Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prothrombin Complex Concentrate (PCC) Drug.
Report Scope
The Prothrombin Complex Concentrate (PCC) Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prothrombin Complex Concentrate (PCC) Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prothrombin Complex Concentrate (PCC) Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CSL Behring
Grifols
Octapharma
Prothya Biosolutions
Takeda
Segment by Type
Beriplex
Profilnine
Octaplex
Prothromplex
Cofact
Other
Segment by Application
Hemophilia B
Acquired Coagulation Factor Deficiency
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Prothrombin Complex Concentrate (PCC) Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Prothrombin Complex Concentrate (PCC) Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available. It may also be used in those with not enough of these factors due to other reasons such as warfarin therapy. It is given by slow injection into a vein.
The global Prothrombin Complex Concentrate (PCC) Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In Europe and United States market, key players of prothrombin complex concentrate (PCC) drug include CSL Behring, Grifols, Octapharma, Prothya Biosolutions, Takeda, etc. The top one player hold a share about 58%. United States is the largest market, has a share about 47%, followed by Germany, and France, with share 13% and 12%, separately.
This report aims to provide a comprehensive presentation of the global market for Prothrombin Complex Concentrate (PCC) Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prothrombin Complex Concentrate (PCC) Drug.
Report Scope
The Prothrombin Complex Concentrate (PCC) Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prothrombin Complex Concentrate (PCC) Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prothrombin Complex Concentrate (PCC) Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CSL Behring
Grifols
Octapharma
Prothya Biosolutions
Takeda
Segment by Type
Beriplex
Profilnine
Octaplex
Prothromplex
Cofact
Other
Segment by Application
Hemophilia B
Acquired Coagulation Factor Deficiency
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Prothrombin Complex Concentrate (PCC) Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Prothrombin Complex Concentrate (PCC) Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Prothrombin Complex Concentrate (PCC) Drug Market Overview
1.1 Product Overview and Scope of Prothrombin Complex Concentrate (PCC) Drug
1.2 Prothrombin Complex Concentrate (PCC) Drug Segment by Type
1.2.1 Global Prothrombin Complex Concentrate (PCC) Drug Market Value Comparison by Type (2024-2030)
1.2.2 Beriplex
1.2.3 Profilnine
1.2.4 Octaplex
1.2.5 Prothromplex
1.2.6 Cofact
1.2.7 Other
1.3 Prothrombin Complex Concentrate (PCC) Drug Segment by Application
1.3.1 Global Prothrombin Complex Concentrate (PCC) Drug Market Value by Application: (2024-2030)
1.3.2 Hemophilia B
1.3.3 Acquired Coagulation Factor Deficiency
1.4 Global Prothrombin Complex Concentrate (PCC) Drug Market Size Estimates and Forecasts
1.4.1 Global Prothrombin Complex Concentrate (PCC) Drug Revenue 2019-2030
1.4.2 Global Prothrombin Complex Concentrate (PCC) Drug Sales 2019-2030
1.4.3 Global Prothrombin Complex Concentrate (PCC) Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Prothrombin Complex Concentrate (PCC) Drug Market Competition by Manufacturers
2.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Manufacturers (2019-2024)
2.4 Global Prothrombin Complex Concentrate (PCC) Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Prothrombin Complex Concentrate (PCC) Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prothrombin Complex Concentrate (PCC) Drug, Product Type & Application
2.7 Prothrombin Complex Concentrate (PCC) Drug Market Competitive Situation and Trends
2.7.1 Prothrombin Complex Concentrate (PCC) Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Prothrombin Complex Concentrate (PCC) Drug Players Market Share by Revenue
2.7.3 Global Prothrombin Complex Concentrate (PCC) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Prothrombin Complex Concentrate (PCC) Drug Retrospective Market Scenario by Region
3.1 Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Prothrombin Complex Concentrate (PCC) Drug Global Prothrombin Complex Concentrate (PCC) Drug Sales by Region: 2019-2030
3.2.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Region: 2019-2024
3.2.2 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Region: 2025-2030
3.3 Global Prothrombin Complex Concentrate (PCC) Drug Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Region: 2019-2030
3.3.1 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Region: 2019-2024
3.3.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Region: 2025-2030
3.4 North America Prothrombin Complex Concentrate (PCC) Drug Market Facts & Figures by Country
3.4.1 North America Prothrombin Complex Concentrate (PCC) Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2019-2030)
3.4.3 North America Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Prothrombin Complex Concentrate (PCC) Drug Market Facts & Figures by Country
3.5.1 Europe Prothrombin Complex Concentrate (PCC) Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2019-2030)
3.5.3 Europe Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Prothrombin Complex Concentrate (PCC) Drug Market Facts & Figures by Country
3.7.1 Latin America Prothrombin Complex Concentrate (PCC) Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2019-2030)
3.7.3 Latin America Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2019-2030)
4.1.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2019-2024)
4.1.2 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2025-2030)
4.1.3 Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2019-2030)
4.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2019-2030)
4.2.1 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2019-2024)
4.2.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2025-2030)
4.2.3 Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Type (2019-2030)
4.3 Global Prothrombin Complex Concentrate (PCC) Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2019-2030)
5.1.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2019-2024)
5.1.2 Global Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2025-2030)
5.1.3 Global Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2019-2030)
5.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2019-2030)
5.2.1 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2019-2024)
5.2.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2025-2030)
5.2.3 Global Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Application (2019-2030)
5.3 Global Prothrombin Complex Concentrate (PCC) Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 CSL Behring
6.1.1 CSL Behring Corporation Information
6.1.2 CSL Behring Description and Business Overview
6.1.3 CSL Behring Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 CSL Behring Prothrombin Complex Concentrate (PCC) Drug Product Portfolio
6.1.5 CSL Behring Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Corporation Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Grifols Prothrombin Complex Concentrate (PCC) Drug Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 Octapharma
6.3.1 Octapharma Corporation Information
6.3.2 Octapharma Description and Business Overview
6.3.3 Octapharma Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Octapharma Prothrombin Complex Concentrate (PCC) Drug Product Portfolio
6.3.5 Octapharma Recent Developments/Updates
6.4 Prothya Biosolutions
6.4.1 Prothya Biosolutions Corporation Information
6.4.2 Prothya Biosolutions Description and Business Overview
6.4.3 Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Product Portfolio
6.4.5 Prothya Biosolutions Recent Developments/Updates
6.5 Takeda
6.5.1 Takeda Corporation Information
6.5.2 Takeda Description and Business Overview
6.5.3 Takeda Prothrombin Complex Concentrate (PCC) Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Takeda Prothrombin Complex Concentrate (PCC) Drug Product Portfolio
6.5.5 Takeda Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prothrombin Complex Concentrate (PCC) Drug Industry Chain Analysis
7.2 Prothrombin Complex Concentrate (PCC) Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prothrombin Complex Concentrate (PCC) Drug Production Mode & Process
7.4 Prothrombin Complex Concentrate (PCC) Drug Sales and Marketing
7.4.1 Prothrombin Complex Concentrate (PCC) Drug Sales Channels
7.4.2 Prothrombin Complex Concentrate (PCC) Drug Distributors
7.5 Prothrombin Complex Concentrate (PCC) Drug Customers
8 Prothrombin Complex Concentrate (PCC) Drug Market Dynamics
8.1 Prothrombin Complex Concentrate (PCC) Drug Industry Trends
8.2 Prothrombin Complex Concentrate (PCC) Drug Market Drivers
8.3 Prothrombin Complex Concentrate (PCC) Drug Market Challenges
8.4 Prothrombin Complex Concentrate (PCC) Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
